This randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved diabetic macular edema (CI-DME) and good visual acuity.

Conditions

  • Diabetic Macular Edema

Intervention

  • Tonabersat
  • Placebo

Principal Investigator

  • Sierpina, David

Sponsor

  • Jaeb Center for Health Research

*The source of data for this particular study is "ClinicalTrials.gov" and was last updated on 05/18/2024. Loma Linda University does not make any warranties, expressed or implied, with respect to such data, and, furthermore, assumes no liability for any party's use, or the results of such use of the data.

Request Information

Complete the form below to contact the study team and receive more information about this trial.